Abstract:With high prevalence of type 2 diabetes worldwide, diabetic complications have been a major health problem, which reduce life quality and induce premature death in adults. The prevalence of type 2 diabetes is closely related to obesity and aging, two major risk factors for metabolic disorders. The diabetic complications, including retinopathy, nephropathy, neuropathy, skin ulcer, and atherosclerosis, are risk factors for mortality of patients. Retinopathy, nephropathy, and skin ulcer are representatives of microvascular complications, which often happen in insulin-deficient diabetic conditions, such as type 1 diabetic patients and some late-stage type 2 diabetic patients when β-cells completely lose function. Atherosclerosis that is often found in type 2 diabetes is a complication of macrovascular disease that increases the risk for myocardial infarction and strokes. However, atherosclerosis is receiving more and more appreciation in type 1 diabetes. Endothelial cells that line the inner vessel have been extensively studied in the mechanism of the diabetic complications. Impaired endothelial cell function is a common cellular mechanism for most of the diabetic complications (retinopathy, nephropathy, skin ulcer, and atherosclerosis). The cells are exposed to the high level of glucose in diabetic condition and subjected to glucose-induced stresses. The stress may cause overproliferation and deficiency in proliferation of endothelial cells, which contribute to dysfunction of microcirculation. Prevention and treatment of the complications are dependent on protection of the endothelial cell functions in most cases. In this issue, the mechanism of endothelial cell dysfunction was investigated in several studies to understand the molecular events by which the endothelial cells are impaired by hyperglycemia. This topic is enhanced with another group of studies about intervention of the endothelial complications with antioxidant compounds and new drug candidates. These studies will help readers to understand the current status and gain new insights into the diabetic complications. Weiping Jia Aimin Xu Alex Chen Jiarui Wu Jianping Ye

Red blood cells as biomarkers and mediators in complications of diabetes mellitus: A review

Role of Circulating Biomarkers in Diabetic Cardiomyopathy

Recent Advances in Computational Modeling of Biomechanics and Biorheology of Red Blood Cells in Diabetes

Sensing Biomechanical Alterations in Red Blood Cells of Type 1 Diabetes Patients: Potential Markers for Microvascular Complications

Changes in red blood cell membrane structure in type 2 diabetes: a scanning electron and atomic force microscopy study

Endothelial dysfunction in vascular complications of diabetes: a comprehensive review of mechanisms and implications

Enhancing endothelial colony-forming cells for treating diabetic vascular complications: challenges and clinical prospects

Depletion Interaction Forces Contribute to Erythrocyte-Endothelial Adhesion in Diabetes

Chronic Vascular Complications in Diabetes

Integrative biology of extracellular vesicles in diabetes mellitus and diabetic complications

Erythrocyte-Derived microRNAs: Emerging Players in Cardiovascular and Metabolic Disease

A Review on Cellular and Molecular Mechanisms Linked to the Development of Diabetes Complications

Imbalances in Mobilization and Activation of Pro-Inflammatory and Vascular Reparative Bone Marrow-Derived Cells in Diabetic Retinopathy

The classical Biomarkers to Predict Diabetes Mellitus

Cell‐based therapy for diabetic cardiovascular complications: Prospects and challenges

Endothelial-to-mesenchymal transition: An underappreciated mediator of diabetic complications

Diabetic Keratopathy: Redox Signaling Pathways and Therapeutic Prospects

Monocytes and Macrophages as Protagonists in Vascular Complications of Diabetes

Red blood cells: a new target to prevent cardiovascular disease?

Key biomarkers in type 2 diabetes patients: A systematic review

Mitochondrial dysfunction and complications associated with diabetes